Ian Binnian

Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial

Sanjay Ramakrishnan, Dan V. Nicolau, Beverly Langford et al. · The Lancet Respiratory Medicine · 2021 · 434 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +13

Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial

Richard J. McManus, Jonathan Mant, Marloes Franssen et al. · The Lancet · 2018 · 419 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial

Rebecca C. Fitzgerald, Massimiliano di Pietro, Maria O’Donovan et al. · The Lancet · 2020 · 253 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +16

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial

Karin Hardt, An Vandebosch, Jerald Sadoff et al. · The Lancet Infectious Diseases · 2022 · 88 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Blood eosinophil-guided oral prednisolone for COPD exacerbations in primary care in the UK (STARR2): a non-inferiority, multicentre, double-blind, placebo-controlled, randomised controlled trial

Sanjay Ramakrishnan, Helen Jeffers, B Langford-Wiley et al. · The Lancet Respiratory Medicine · 2023 · 72 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17